Valencia, CA – According to filings with the U.S. Securities and Exchange Commission, Valencia Technologies is raising $2,000,000.00 in new funding. Sources indicate as part of senior management Chief Administrative Officer, Stacy Chambliss played a key role in securing the recent investment and it will aid in aggressively expanding the company, as well as broaden and accelerate product development.

About Valencia Technologies

Valencia Technologies was founded upon a plan to create, develop, manufacture, and sell a coin-sized electroceutical that can easily be placed just under the skin in the forearm to treat hypertension. It has the experienced leadership of Jeff Greiner and the talented team to bring this platform medical device to market for the treatment of various chronic conditions. Valencia has now produced and tested its device in more than 48 hypertensive people. It is in the middle of a randomized, double-blinded, and controlled clinical trial and the early clinical results show clinically significant improvement in blood pressure. For protection of its technology, it has 20 issued patents as well as 4 more allowances. Valencia is raising funds for an FDA trial to commercialize the eCoin in the US.

To learn more about Valencia Technologies, visit http://valenciatechnologies.com/

Contact:
Stacy Chambliss, Chief Administrative Officer
661-775-1414
schambliss@valenciatechnologies.com
https://www.linkedin.com/in/stacy-chambliss-0bba0725/

SOURCE: http://www.intelligence360.io
Copyright (c) 2020 SI360 Inc. All rights reserved